| Firm | Analyst |
|---|---|
| Brookline Capital Markets | Kumar Raja |
| Guggenheim Securities | Vamil Divan, M.D. |
| Maxim Group | Jason McCarthy, Ph.D. |
| Noble Life Science Partners | Robert LeBoyer |
| Piper Sandler | Yasmeen Rahimi, Ph.D. |
| The Benchmark Company, LLC | Bruce Jackson |
Unicycive Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Unicycive Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Unicycive Therapeutics, Inc. or its management. Unicycive Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.